Works matching IS 08876924 AND DT 2015 AND VI 29 AND IP 6

Results: 30

HIF-1α is required for hematopoietic stem cell mobilization and 4-prolyl hydroxylase inhibitors enhance mobilization by stabilizing HIF-1α.

Published in:

2015

By:

Forristal, C E;
Nowlan, B;
Jacobsen, R N;
Barbier, V;
Walkinshaw, G;
Walkley, C R;
Winkler, I G;
Levesque, J P

Publication type:

journal article

Colony-stimulating factor-3 receptor, watch out for polymorphisms.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1445, doi. 10.1038/leu.2015.25

By:

Bilbao-Sieyro, C;
Santana, G;
Torres-Miñana, L;
Rodriguez-Medina, C;
Saez, M N;
Perera, M;
Lemes, Angelina;
de la Iglesia, S;
Molero, T;
Gomez-Casares, M T

Publication type:

Article

Involvement of double-stranded RNA-dependent protein kinase and antisense viral RNA in the constitutive NF[kappa]B activation in adult T-cell leukemia/lymphoma cells.

Published in:

2015

By:

Kinpara, S;
Ito, S;
Takahata, T;
Saitoh, Y;
Hasegawa, A;
Kijiyama, M;
Utsunomiya, A;
Masuda, M;
Miyazaki, Y;
Matsuoka, M;
Nakamura, M;
Yamaoka, S;
Masuda, T;
Kannagi, M

Publication type:

Journal Article

Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells.

Published in:

2015

By:

Fiskus, W;
Sharma, S;
Saha, S;
Shah, B;
Devaraj, S G T;
Sun, B;
Horrigan, S;
Leveque, C;
Zu, Y;
Iyer, S;
Bhalla, K N

Publication type:

journal article

Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1301, doi. 10.1038/leu.2015.27

By:

Witkowski, M T;
Cimmino, L;
Hu, Y;
Trimarchi, T;
Tagoh, H;
McKenzie, M D;
Best, S A;
Tuohey, L;
Willson, T A;
Nutt, S L;
Busslinger, M;
Aifantis, I;
Smyth, G K;
Dickins, R A

Publication type:

Article

A randomised comparison of the novel nucleoside analogue sapacitabine with low-dose cytarabine in older patients with acute myeloid leukaemia.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1312, doi. 10.1038/leu.2015.38

By:

Burnett, A K;
Russell, N;
Hills, R K;
Panoskaltsis, N;
Khwaja, A;
Hemmaway, C;
Cahalin, P;
Clark, R E;
Milligan, D

Publication type:

Article

Involvement of double-stranded RNA-dependent protein kinase and antisense viral RNA in the constitutive NFκB activation in adult T-cell leukemia/lymphoma cells.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1425, doi. 10.1038/leu.2015.1

By:

Kinpara, S;
Ito, S;
Takahata, T;
Saitoh, Y;
Hasegawa, A;
Kijiyama, M;
Utsunomiya, A;
Masuda, M;
Miyazaki, Y;
Matsuoka, M;
Nakamura, M;
Yamaoka, S;
Masuda, T;
Kannagi, M

Publication type:

Article

Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1344, doi. 10.1038/leu.2015.87

By:

Palandri, F;
Latagliata, R;
Polverelli, N;
Tieghi, A;
Crugnola, M;
Martino, B;
Perricone, M;
Breccia, M;
Ottaviani, E;
Testoni, N;
Merli, F;
Aversa, F;
Alimena, G;
Cavo, M;
Martinelli, G;
Catani, L;
Baccarani, M;
Vianelli, N

Publication type:

Article

Interferon alpha 2 maintenance therapy may enable high rates of treatment discontinuation in chronic myeloid leukemia.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1331, doi. 10.1038/leu.2015.45

By:

Burchert, A;
Saussele, S;
Eigendorff, E;
Müller, M C;
Sohlbach, K;
Inselmann, S;
Schütz, C;
Metzelder, S K;
Ziermann, J;
Kostrewa, P;
Hoffmann, J;
Hehlmann, R;
Neubauer, A;
Hochhaus, A

Publication type:

Article

Epigenomic analysis of the HOX gene loci reveals mechanisms that may control canonical expression patterns in AML and normal hematopoietic cells.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1279, doi. 10.1038/leu.2015.6

By:

Spencer, D H;
Young, M A;
Lamprecht, T L;
Helton, N M;
Fulton, R;
O'Laughlin, M;
Fronick, C;
Magrini, V;
Demeter, R T;
Miller, C A;
Klco, J M;
Wilson, R K;
Ley, T J

Publication type:

Article

CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1437, doi. 10.1038/leu.2015.10

By:

Gregory, G P;
Hogg, S J;
Kats, L M;
Vidacs, E;
Baker, A J;
Gilan, O;
Lefebure, M;
Martin, B P;
Dawson, M A;
Johnstone, R W;
Shortt, J

Publication type:

Article

L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1253, doi. 10.1038/leu.2014.338

By:

Rosilio, C;
Nebout, M;
Imbert, V;
Griessinger, E;
Neffati, Z;
Benadiba, J;
Hagenbeek, T;
Spits, H;
Reverso, J;
Ambrosetti, D;
Michiels, J-F;
Bailly-Maitre, B;
Endou, H;
Wempe, M F;
Peyron, J-F

Publication type:

Article

A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1390, doi. 10.1038/leu.2014.347

By:

Abate, F;
Todaro, M;
van der Krogt, J-A;
Boi, M;
Landra, I;
Machiorlatti, R;
Tabbò, F;
Messana, K;
Abele, C;
Barreca, A;
Novero, D;
Gaudiano, M;
Aliberti, S;
Di Giacomo, F;
Tousseyn, T;
Lasorsa, E;
Crescenzo, R;
Bessone, L;
Ficarra, E;
Acquaviva, A

Publication type:

Article

Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1360, doi. 10.1038/leu.2015.21

By:

Mauro, F R;
Chauvie, S;
Paoloni, F;
Biggi, A;
Cimino, G;
Rago, A;
Gentile, M;
Morabito, F;
Coscia, M;
Bellò, M;
Sacchetti, G M;
Rossi, D;
Laurenti, L;
Autore, F;
Campanelli, M;
Trastulli, F;
Nicolai, E;
Riminucci, M;
Gaidano, G;
Guarini, A

Publication type:

Article

Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1243, doi. 10.1038/leu.2015.32

By:

Bochtler, T;
Fröhling, S;
Krämer, A

Publication type:

Article

Targeting PD1-PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1441, doi. 10.1038/leu.2015.11

By:

Ray, A;
Das, D S;
Song, Y;
Richardson, P;
Munshi, N C;
Chauhan, D;
Anderson, K C

Publication type:

Article

Mutated Ptpn11 alters leukemic stem cell frequency and reduces the sensitivity of acute myeloid leukemia cells to Mcl1 inhibition.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1290, doi. 10.1038/leu.2015.18

By:

Chen, L;
Chen, W;
Mysliwski, M;
Serio, J;
Ropa, J;
Abulwerdi, F A;
Chan, R J;
Patel, J P;
Tallman, M S;
Paietta, E;
Melnick, A;
Levine, R L;
Abdel-Wahab, O;
Nikolovska-Coleska, Z;
Muntean, A G

Publication type:

Article

Replication factor C3 is a CREB target gene that regulates cell cycle progression through the modulation of chromatin loading of PCNA.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1379, doi. 10.1038/leu.2014.350

By:

Chae, H-D;
Mitton, B;
Lacayo, N J;
Sakamoto, K M

Publication type:

Article

Early B-cell-specific inactivation of ATM synergizes with ectopic CyclinD1 expression to promote pre-germinal center B-cell lymphomas in mice.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1414, doi. 10.1038/leu.2015.41

By:

Yamamoto, K;
Lee, B J;
Li, C;
Dubois, R L;
Hobeika, E;
Bhagat, G;
Zha, S

Publication type:

Article

Allelic imbalance in CALR somatic mutagenesis.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1431, doi. 10.1038/leu.2015.3

By:

Harutyunyan, A S;
Jäger, R;
Chen, D;
Berg, T;
Rumi, E;
Gisslinger, B;
Pietra, D;
Gisslinger, H;
Cazzola, M;
Kralovics, R

Publication type:

Article

Imprinted genes in myeloid lineage commitment in normal and malignant hematopoiesis.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1233, doi. 10.1038/leu.2015.47

By:

Benetatos, L;
Vartholomatos, G

Publication type:

Article

KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1223, doi. 10.1038/leu.2015.24

By:

Arock, M;
Sotlar, K;
Akin, C;
Broesby-Olsen, S;
Hoermann, G;
Escribano, L;
Kristensen, T K;
Kluin-Nelemans, H C;
Hermine, O;
Dubreuil, P;
Sperr, W R;
Hartmann, K;
Gotlib, J;
Cross, N C P;
Haferlach, T;
Garcia-Montero, A;
Orfao, A;
Schwaab, J;
Triggiani, M;
Horny, H-P

Publication type:

Article

The role of Lin28b in myeloid and mast cell differentiation and mast cell malignancy.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1320, doi. 10.1038/leu.2015.19

By:

Wang, L D;
Rao, T N;
Rowe, R G;
Nguyen, P T;
Sullivan, J L;
Pearson, D S;
Doulatov, S;
Wu, L;
Lindsley, R C;
Zhu, H;
DeAngelo, D J;
Daley, G Q;
Wagers, A J

Publication type:

Article

The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1336, doi. 10.1038/leu.2015.73

By:

Hoffmann, V S;
Baccarani, M;
Hasford, J;
Lindoerfer, D;
Burgstaller, S;
Sertic, D;
Costeas, P;
Mayer, J;
Indrak, K;
Everaus, H;
Koskenvesa, P;
Guilhot, J;
Schubert-Fritschle, G;
Castagnetti, F;
Di Raimondo, F;
Lejniece, S;
Griskevicius, L;
Thielen, N;
Sacha, T;
Hellmann, A

Publication type:

Article

BIN1 tumor suppressor regulates Fas/Fas ligand-mediated apoptosis through c-FLIP in cutaneous T-cell lymphoma.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1402, doi. 10.1038/leu.2015.9

By:

Esmailzadeh, S;
Huang, Y;
Su, M-W;
Zhou, Y;
Jiang, X

Publication type:

Article

Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1267, doi. 10.1038/leu.2014.340

By:

Fiskus, W;
Sharma, S;
Saha, S;
Shah, B;
Devaraj, S G T;
Sun, B;
Horrigan, S;
Leveque, C;
Zu, Y;
Iyer, S;
Bhalla, K N

Publication type:

Article

Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1429, doi. 10.1038/leu.2015.2

By:

Purdue, M P;
Lan, Q;
Kemp, T J;
Hildesheim, A;
Weinstein, S J;
Hofmann, J N;
Virtamo, J;
Albanes, D;
Pinto, L A;
Rothman, N

Publication type:

Article

HIF-1α is required for hematopoietic stem cell mobilization and 4-prolyl hydroxylase inhibitors enhance mobilization by stabilizing HIF-1α.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1366, doi. 10.1038/leu.2015.8

By:

Forristal, C E;
Nowlan, B;
Jacobsen, R N;
Barbier, V;
Walkinshaw, G;
Walkley, C R;
Winkler, I G;
Levesque, J P

Publication type:

Article

PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse model.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1350, doi. 10.1038/leu.2014.341

By:

Motiwala, T;
Kutay, H;
Zanesi, N;
Frissora, F W;
Mo, X;
Muthusamy, N;
Jacob, S T

Publication type:

Article

The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolution.

Published in:

Leukemia (08876924), 2015, v. 29, n. 6, p. 1435, doi. 10.1038/leu.2015.7

By:

Puig, N;
Conde, I;
Jiménez, C;
Sarasquete, M E;
Balanzategui, A;
Alcoceba, M;
Quintero, J;
Chillón, M C;
Sebastián, E;
Corral, R;
Marín, L;
Gutiérrez, N C;
Mateos, M-V;
González-Díaz, M;
San-Miguel, J F;
García-Sanz, R

Publication type:

Article